Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study-Reference-Cited by-同舟云学术

Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study

Published:2018-10-05 Issue:12 Volume:45 Page:1425-1433
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Sumida Hayakazu¹,Asano Yoshihide¹^ORCID,Tamaki Zenshiro¹,Aozasa Naohiko¹^ORCID,Taniguchi Takashi¹^ORCID,Toyama Tetsuo¹,Takahashi Takehiro¹,Ichimura Yohei¹,Noda Shinji¹,Akamata Kaname¹,Saigusa Ryosuke¹,Miyazaki Miki¹,Kuwano Yoshihiro¹,Yanaba Koichi¹^ORCID,Yoshizaki Ayumi¹,Sato Shinichi¹

Affiliation:

1. Department of Dermatology; Faculty of Medicine; The University of Tokyo; Tokyo Japan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1346-8138.14669/fullpdf

Reference34 articles.

1. Future treatments in systemic sclerosis;Asano;J Dermatol,2010

2. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody;Steen;J Rheumatol,2007

3. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population;Mayes;Arthritis Rheum,2003